These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 21274273)
1. Androgen receptor signalling in prostate cancer: the functional consequences of acetylation. Lavery DN; Bevan CL J Biomed Biotechnol; 2011; 2011():862125. PubMed ID: 21274273 [TBL] [Abstract][Full Text] [Related]
2. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977 [TBL] [Abstract][Full Text] [Related]
3. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. Gaughan L; Logan IR; Cook S; Neal DE; Robson CN J Biol Chem; 2002 Jul; 277(29):25904-13. PubMed ID: 11994312 [TBL] [Abstract][Full Text] [Related]
4. Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer. Jaiswal B; Agarwal A; Gupta A Front Endocrinol (Lausanne); 2022; 13():886594. PubMed ID: 36060957 [TBL] [Abstract][Full Text] [Related]
6. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
7. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Miyajima N; Maruyama S; Bohgaki M; Kano S; Shigemura M; Shinohara N; Nonomura K; Hatakeyama S Cancer Res; 2008 May; 68(9):3486-94. PubMed ID: 18451177 [TBL] [Abstract][Full Text] [Related]
8. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens. Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832 [TBL] [Abstract][Full Text] [Related]
9. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells. Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293 [TBL] [Abstract][Full Text] [Related]
11. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells. Kim JY; Yu J; Abdulkadir SA; Chakravarti D Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279 [TBL] [Abstract][Full Text] [Related]
12. Expression and function of androgen receptor coactivators in prostate cancer. Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989 [TBL] [Abstract][Full Text] [Related]
13. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687 [TBL] [Abstract][Full Text] [Related]
14. 5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription. Sharma M; Sun Z Mol Endocrinol; 2001 Nov; 15(11):1918-28. PubMed ID: 11682623 [TBL] [Abstract][Full Text] [Related]
15. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Yoon HG; Wong J Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395 [TBL] [Abstract][Full Text] [Related]
16. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Gibbs A; Schwartzman J; Deng V; Alumkal J Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16663-8. PubMed ID: 19805354 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants. Korkmaz CG; Frønsdal K; Zhang Y; Lorenzo PI; Saatcioglu F J Endocrinol; 2004 Sep; 182(3):377-89. PubMed ID: 15350180 [TBL] [Abstract][Full Text] [Related]
18. Acetylation of nuclear receptors in cellular growth and apoptosis. Fu M; Wang C; Zhang X; Pestell RG Biochem Pharmacol; 2004 Sep; 68(6):1199-208. PubMed ID: 15313417 [TBL] [Abstract][Full Text] [Related]
19. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Fu M; Rao M; Wang C; Sakamaki T; Wang J; Di Vizio D; Zhang X; Albanese C; Balk S; Chang C; Fan S; Rosen E; Palvimo JJ; Jänne OA; Muratoglu S; Avantaggiati ML; Pestell RG Mol Cell Biol; 2003 Dec; 23(23):8563-75. PubMed ID: 14612401 [TBL] [Abstract][Full Text] [Related]
20. Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor. Choi KC; Park S; Lim BJ; Seong AR; Lee YH; Shiota M; Yokomizo A; Naito S; Na Y; Yoon HG Biochem J; 2011 Jan; 433(1):235-44. PubMed ID: 20955177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]